Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tardive dyskinesia].

F Sabbatini, S Gentile, M De Mattei

    Minerva Medica
    |April 14, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Neuroleptic medications can cause tardive dyskinesia, a movement disorder. This review covers its incidence, risk factors, symptoms, diagnosis, and potential treatments linked to dopamine receptor hypersensitivity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A mathematical model for the evaluation of iron transport across the blood-cerebrospinal fluid barrier in neurodegenerative diseases.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
    Same author

    A novel neurocognitive approach for placebo analgesia in neurocognitive disorders.

    Experimental gerontology·2019
    Same author

    Chemotherapy-Induced Neurotoxicity: Evidence of a Protective Role of CC Homozygosis in the Interleukin-1β Gene-511 C>T Polymorphism.

    Neurotoxicity research·2016
    Same author

    Evaluation of the Electroporation Efficiency of a Grid Electrode for Electrochemotherapy: From Numerical Model to In Vitro Tests.

    Technology in cancer research & treatment·2015
    Same author

    Measurement of the charge asymmetry in top quark pair production in <i>pp</i> collisions at [Formula: see text] using the ATLAS detector.

    The European physical journal. C, Particles and fields·2015
    Same author

    Search for Higgs boson pair production in the γγbb[over ¯] final state using pp collision data at sqrt[s]=8  TeV from the ATLAS detector.

    Physical review letters·2015
    Same journal

    How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

    Minerva medica·2026
    Same journal

    Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

    Minerva medica·2026
    Same journal

    Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

    Minerva medica·2026
    Same journal

    Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

    Minerva medica·2026
    Same journal

    Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

    Minerva medica·2026
    Same journal

    Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

    Minerva medica·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Clinical Neurology

    Context:

    • Neuroleptic drug therapy is a common treatment for various psychiatric conditions.
    • Tardive dyskinesia (TD) is a recognized, potentially irreversible side effect of long-term neuroleptic use.
    • Understanding TD is crucial for patient safety and effective treatment management.

    Purpose:

    • To comprehensively review the incidence, risk factors, and clinical presentation of tardive dyskinesia.
    • To discuss the diagnostic challenges associated with tardive dyskinesia.
    • To explore potential therapeutic strategies for tardive dyskinesia.

    Summary:

    • Neuroleptic drug treatment is associated with the development of tardive dyskinesia (TD).
    • This review details the incidence, risk factors, clinical characteristics, and differential diagnosis of TD.

    Related Experiment Videos

  • Therapeutic approaches are considered, focusing on the hypothesis of physiopathological dopamine receptor hypersensitivity.

    • Impact:

    • Provides a consolidated overview of tardive dyskinesia for clinicians and researchers.
    • Highlights the importance of recognizing and managing this adverse drug effect.
    • Informs potential future research directions and therapeutic interventions for dopamine receptor-related disorders.